Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dong-A ST Co., Ltd.
A multicenter, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy of Acetyl-L-carnitine in patient with Alzheimer's disease
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
More than 50 Years
probable Alzheimer disease according to DSM-IV and NINCDS-ADRDA standard
12≤K-MMSE(screening)≤26
be able to perform examinations
Patient taking donepezil(5mg or 10mg/day) more than 3 months
be able to visit to hospital with caregiver
You may not be if
possible or probable or definite vascular dementia according to NINDS-AIREN standard
CNS disease(Cerebrovascular diseases, Epilepsy etc) to cause dementia
Illiteracy
Patient taking galantamine, memantine, rivastigmine within three months
Patient taking brain enhancer, thyroid hormone within 4 weeks
Patient taking Central nervous system stimulant, Antipsychotic agent, anticholinergic agent within 2 weeks
at screenig blood test: AST, ALT≥ 3 X upper limit of normal range or Hb≤8g/dL or platelet\<100,000/mm3 or Serum creatinine ≥ 3 X upper limit of normal range
Abnormal result of Vit.B12, Syphilis serology, TSH
Severe Depression, Schizophrenia, Alcoholism, Drug addiction
Parkinson's disease (need to drug therapy)
Angina, Myocardial infarction, ischemia within six months
